• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

定义 COVID-19 的短期和长期皮肤表现:大流行三年多后的洞察。

Defining the short-term and long-term skin manifestations of COVID-19: insights after more than three years of the pandemic.

机构信息

Department of Urology, Department of Dermatology, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, Romania;

出版信息

Rom J Morphol Embryol. 2023 Jul-Sep;64(3):291-304. doi: 10.47162/RJME.64.3.01.

DOI:10.47162/RJME.64.3.01
PMID:37867347
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10720941/
Abstract

AIM

This review aimed to assess the impact of coronavirus disease 2019 (COVID-19) on skin health to establish a classification of the skin lesions that occur most frequently during the disease and whether a particular category of skin damage is more likely to occur both in the short term and in the long term.

METHODS

We conducted a literature search of the PubMed database. Ultimately, 109 articles were included in this review. The exact phrases∕syntax and connectors used for the database search∕query were as follows: "Coronavirus and skin", "COVID-19 and skin", "SARS-CoV-2 and skin", "Coronavirus cutaneous manifestations", "COVID-19 cutaneous manifestations", "SARS-CoV-2 cutaneous manifestations", "Coronavirus dermatology", "SARS-CoV-2 and dermatology", "COVID-19 and dermatology", "COVID-19 and skin eruption", "Coronavirus and skin rash", "COVID-19 and hair", "Coronavirus and hair", "Coronavirus and nails", "SARS-CoV-2 and hair", and "SARS-CoV-2 and nails". Only articles with abstracts referring strictly to cutaneous manifestations of COVID-19 were chosen. Articles without abstracts were not considered.

RESULTS

We established six of the most frequently reported clinical patterns associated with COVID-19 and their probability of occurring during COVID-19 disease evolution based on the current literature reports. We did not identify the particular types of skin lesions that are most prone to long-term persistence; most such cases are rare, and no conclusion can be drawn based on them.

CONCLUSIONS

Apart from classified COVID-19-related skin disorders, this pandemic has been a challenge for dermatologists and a wide range of cutaneous side effects related to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) treatments have been reported. We are aware of other polymorphic clinical presentations, with novel data being reported periodically, but the pathophysiological mechanisms and evolution are largely unknown.

摘要

目的

本综述旨在评估 2019 年冠状病毒病(COVID-19)对皮肤健康的影响,建立疾病过程中最常发生的皮肤病变分类,以及是否有特定类别的皮肤损伤更有可能在短期和长期内发生。

方法

我们对 PubMed 数据库进行了文献检索。最终,有 109 篇文章被纳入本综述。数据库检索/查询中使用的确切短语/语法和连接词如下:“冠状病毒和皮肤”、“COVID-19 和皮肤”、“SARS-CoV-2 和皮肤”、“冠状病毒皮肤表现”、“COVID-19 皮肤表现”、“SARS-CoV-2 皮肤表现”、“冠状病毒皮肤病学”、“SARS-CoV-2 和皮肤病学”、“COVID-19 和皮肤病学”、“COVID-19 和皮肤疹”、“冠状病毒和皮疹”、“COVID-19 和头发”、“冠状病毒和头发”、“冠状病毒和指甲”、“SARS-CoV-2 和头发”和“SARS-CoV-2 和指甲”。仅选择了那些摘要严格提及 COVID-19 皮肤表现的文章。没有摘要的文章未被考虑。

结果

根据目前的文献报告,我们确定了与 COVID-19 相关的六种最常报告的临床模式及其在 COVID-19 疾病演变过程中的发生概率。我们没有确定最容易长期持续存在的特定类型的皮肤损伤;大多数此类病例较为罕见,无法根据它们得出结论。

结论

除了分类的 COVID-19 相关皮肤疾病外,这场大流行对皮肤科医生来说也是一个挑战,并且已经报道了与严重急性呼吸系统综合征冠状病毒 2(SARS-CoV-2)治疗相关的广泛的皮肤副作用。我们知道其他多态性临床表现,定期有新数据报告,但病理生理机制和演变在很大程度上是未知的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a11/10720941/f5057301334d/RJME-64-3-291-fig13.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a11/10720941/a1dce95422d5/RJME-64-3-291-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a11/10720941/6b9554aacff7/RJME-64-3-291-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a11/10720941/0dca0dc2631e/RJME-64-3-291-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a11/10720941/bd317eacaeb4/RJME-64-3-291-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a11/10720941/c23bb1433e2a/RJME-64-3-291-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a11/10720941/90cecc7653c2/RJME-64-3-291-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a11/10720941/ef1c352ae6d8/RJME-64-3-291-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a11/10720941/6823f6711f0b/RJME-64-3-291-fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a11/10720941/bcecb1cc7390/RJME-64-3-291-fig9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a11/10720941/8916f2952c5f/RJME-64-3-291-fig10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a11/10720941/3fbbcc92e0e7/RJME-64-3-291-fig11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a11/10720941/901a70768f09/RJME-64-3-291-fig12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a11/10720941/f5057301334d/RJME-64-3-291-fig13.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a11/10720941/a1dce95422d5/RJME-64-3-291-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a11/10720941/6b9554aacff7/RJME-64-3-291-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a11/10720941/0dca0dc2631e/RJME-64-3-291-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a11/10720941/bd317eacaeb4/RJME-64-3-291-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a11/10720941/c23bb1433e2a/RJME-64-3-291-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a11/10720941/90cecc7653c2/RJME-64-3-291-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a11/10720941/ef1c352ae6d8/RJME-64-3-291-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a11/10720941/6823f6711f0b/RJME-64-3-291-fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a11/10720941/bcecb1cc7390/RJME-64-3-291-fig9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a11/10720941/8916f2952c5f/RJME-64-3-291-fig10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a11/10720941/3fbbcc92e0e7/RJME-64-3-291-fig11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a11/10720941/901a70768f09/RJME-64-3-291-fig12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a11/10720941/f5057301334d/RJME-64-3-291-fig13.jpg

相似文献

1
Defining the short-term and long-term skin manifestations of COVID-19: insights after more than three years of the pandemic.定义 COVID-19 的短期和长期皮肤表现:大流行三年多后的洞察。
Rom J Morphol Embryol. 2023 Jul-Sep;64(3):291-304. doi: 10.47162/RJME.64.3.01.
2
Cutaneous manifestations of SARS-CoV-2 infection: a clinical update.新型冠状病毒感染的皮肤表现:临床最新进展。
J Eur Acad Dermatol Venereol. 2020 Nov;34(11):2499-2504. doi: 10.1111/jdv.16774. Epub 2020 Jul 20.
3
Cutaneous Manifestation in COVID-19: A Lesson Over 2 Years Into the Pandemic.COVID-19 相关皮肤表现:大流行 2 年多来的教训。
Clin Med Res. 2023 Mar;21(1):36-45. doi: 10.3121/cmr.2023.1598.
4
Identification, Mechanism, and Treatment of Skin Lesions in COVID-19: A Review.《COVID-19 相关皮肤损伤的识别、机制与治疗:综述》。
Viruses. 2021 Sep 24;13(10):1916. doi: 10.3390/v13101916.
5
Pathobiology of Cutaneous Manifestations Associated with COVID-19 and Their Management.与 COVID-19 相关的皮肤表现的病理生物学及其管理。
Viruses. 2022 Sep 6;14(9):1972. doi: 10.3390/v14091972.
6
[COVID-19 and skin manifestations: overview of current literature].[新型冠状病毒肺炎与皮肤表现:当前文献综述]
Hautarzt. 2022 Apr;73(4):291-297. doi: 10.1007/s00105-022-04961-2. Epub 2022 Mar 7.
7
Cutaneous manifestations in children with SARS-CoV-2 infection and/or COVID-19: what do we know after 10 months under this pandemic?儿童 SARS-CoV-2 感染和/或 COVID-19 的皮肤表现:在这场大流行下的 10 个月后,我们了解到了什么?
Int J Dermatol. 2022 Jan;61(1):39-45. doi: 10.1111/ijd.15882. Epub 2021 Sep 16.
8
Cutaneous manifestations in patients with coronavirus disease 2019: clinical and histological findings.新型冠状病毒肺炎患者的皮肤表现:临床和组织学观察。
Hum Pathol. 2021 Jan;107:39-45. doi: 10.1016/j.humpath.2020.10.011. Epub 2020 Nov 5.
9
Cutaneous manifestations in patients with COVID-19: a preliminary review of an emerging issue.新型冠状病毒肺炎患者的皮肤表现:一个新出现问题的初步综述
Br J Dermatol. 2020 Sep;183(3):431-442. doi: 10.1111/bjd.19264. Epub 2020 Jul 5.
10
Cutaneous manifestations of the COVID-19 pandemic in schoolchildren and adolescents.儿童和青少年中 COVID-19 大流行的皮肤表现。
Acta Dermatovenerol Alp Pannonica Adriat. 2023 Dec;32(4):173-181.

引用本文的文献

1
Postoperative multiple perforations of the small bowel in a patient with COVID-19 - case report.COVID-19 患者术后小肠多发性穿孔-病例报告。
Rom J Morphol Embryol. 2024 Jul-Sep;65(3):531-535. doi: 10.47162/RJME.65.3.16.
2
Overlapping conditions in Long COVID at a multisite academic center.多中心学术机构中长新冠的重叠病症
Front Neurol. 2024 Oct 25;15:1482917. doi: 10.3389/fneur.2024.1482917. eCollection 2024.
3
Long COVID in Children, Adults, and Vulnerable Populations: A Comprehensive Overview for an Integrated Approach.

本文引用的文献

1
Viruses, Variants, and Vaccines: How COVID-19 Has Changed the Way We Look at Skin.病毒、变种与疫苗:新冠疫情如何改变我们对皮肤的看法。
Curr Dermatol Rep. 2022;11(4):289-312. doi: 10.1007/s13671-022-00370-9. Epub 2022 Oct 17.
2
Cutaneous manifestations of SARS-CoV-2 infection during the Delta and Omicron waves in 348 691 UK users of the UK ZOE COVID Study app.英国 ZOE COVID 研究应用程序 348691 名用户中德尔塔和奥密克戎变异株流行期间的 SARS-CoV-2 感染的皮肤表现。
Br J Dermatol. 2022 Dec;187(6):900-908. doi: 10.1111/bjd.21784. Epub 2022 Oct 10.
3
New-onset and exacerbated skin diseases after COVID-19 infection: A systematic review.
儿童、成人及弱势群体中的新冠长期症状:综合概述与综合应对方法
Diseases. 2024 May 6;12(5):95. doi: 10.3390/diseases12050095.
4
The Aftermath of COVID-19: Exploring the Long-Term Effects on Organ Systems.新冠疫情的后果:探索对器官系统的长期影响
Biomedicines. 2024 Apr 20;12(4):913. doi: 10.3390/biomedicines12040913.
新型冠状病毒肺炎感染后新发及加重的皮肤疾病:一项系统综述
J Dermatol. 2022 Nov;49(11):e419-e421. doi: 10.1111/1346-8138.16501. Epub 2022 Jul 1.
4
Increased Predisposition of SJS TEN in COVID-19 Patients, Presenting as Post COVID Complication: Report of Two Cases.新冠病毒感染患者发生中毒性表皮坏死松解症和史蒂文斯-约翰逊综合征的易感性增加,表现为新冠后并发症:两例报告
Indian Dermatol Online J. 2022 Mar 3;13(2):237-239. doi: 10.4103/idoj.idoj_510_21. eCollection 2022 Mar-Apr.
5
Prevalence and patterns of cutaneous manifestations in 1245 COVID-19 patients in Japan: a single-centre study.日本1245例COVID-19患者皮肤表现的患病率及模式:一项单中心研究。
J Eur Acad Dermatol Venereol. 2022 Jul;36(7):e522-e524. doi: 10.1111/jdv.18062. Epub 2022 Mar 18.
6
Persisting Symptoms After COVID-19.新冠病毒感染后持续存在的症状。
Dtsch Arztebl Int. 2022 Mar 11;119(10):167-174. doi: 10.3238/arztebl.m2022.0147.
7
Long-term complications of COVID-19.COVID-19 的长期并发症。
Am J Physiol Cell Physiol. 2022 Jan 1;322(1):C1-C11. doi: 10.1152/ajpcell.00375.2021. Epub 2021 Nov 24.
8
COVID-19-related skin manifestations: Update on therapy.COVID-19 相关皮肤表现:治疗进展。
Clin Dermatol. 2021 Sep-Oct;39(5):920-926. doi: 10.1016/j.clindermatol.2020.12.003. Epub 2020 Dec 14.
9
COVID-19 induced telogen effluvium.COVID-19 引发的休止期脱发。
Dermatol Ther. 2021 Nov;34(6):e15175. doi: 10.1111/dth.15175. Epub 2021 Nov 6.
10
Identification, Mechanism, and Treatment of Skin Lesions in COVID-19: A Review.《COVID-19 相关皮肤损伤的识别、机制与治疗:综述》。
Viruses. 2021 Sep 24;13(10):1916. doi: 10.3390/v13101916.